Comparison of effects of isotonic sodium chloride with diltiazem in prevention of contrast-induced nephropathy

References

• Detrenis S, Meschi M, Musini S, Savazzi G. Lights and shadows on the pathogenesis of lights and shadows on the pathogenesis of contrast-induced nephropathy: state of the art. Nephrol Dial Transplant. 2005;20(8):1542–1550
   PubMedGoogle Scholar
• Thomsen HS, Morcos SK. Contrast media and the kidney: European society of urogenital radiology (ESUR) guidelines. Br J Radiol. 2003;76(908):513–518
   PubMed Web of Science ®Google Scholar
• Rihal CS, Textor SC, Grill DE, et al. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation. 2002;105(19):2259–2264
   PubMed Web of Science ®Google Scholar
• Lufft V, Hoogestraat-Lufft L, Fels LM, et al. Angiography for renal artery stenosis: no additional impairment of renal function by angioplasty. Eur Radiol. 2002;12(4):804–809
   PubMedGoogle Scholar
• Erley CM, Duda SH, Rehfuss D, et al. Prevention of radiocontrast- media-induced nephropathy in patients with pre-axisting renal insufficiency by hydration in combination with the adenosine antagonit theophylline. Nephrol Dial Transplant. 1999;14:1146–1149
   PubMed Web of Science ®Google Scholar
• Cavusoglu E, Chhabra S, Marmur JD, et al. The prevention of contrast-induced nephropathy in patients undergoing percutaneous coronary intervention. Prog Cardiovasc Dis. 2003;45(6):493–503
   PubMedGoogle Scholar
• Moos SI, Stoker J, Beenen LF, Flobbe K, Bipat S. The prevention of contrast-induced nephropathy in Dutch hospitals. Neth J Med. 2013;71(2):97–103
   PubMedGoogle Scholar
• Alessandri N, Lanzi L, Garante CM, et al. Prevention of acute renal failure post-contrast imaging in cardiology: a randomized study. Eur Rev Med Pharmacol Sci. 2013;17:13–21
   PubMedGoogle Scholar
• Okumura K, Sone T. Risk assessment and prevention of contrast-induced nephropathy in patients undergoing coronary angiography. Intern Med. 2012;51(6):519–521
   PubMedGoogle Scholar
• Dangas G, Iakovou I, Nikolsky E, et al. Contrast-induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variables. Am J Cardiol. 2005;95:13–19
   PubMed Web of Science ®Google Scholar
• Solomon R, Werner C, Mann D, et al. Effects of saline, mannitol and furosemide on acute decreases in renal function induced by radiocontrast agents. New Eng J Med. 1994;331(21):1416–1420
   PubMed Web of Science ®Google Scholar
• Weinstein JM, Heyman S, Brezis M. Potential deleterious effect of furosemide in radiocontrast nephropathy. Nephron. 1992;62:413–415
   PubMed Web of Science ®Google Scholar
• Sudarsky D, Nikolsky E. Contrast-induced nephropathy in interventional cardiology. Int J Nephrol Renovasc Dis. 2011;4:85–99
   PubMedGoogle Scholar
• Baptista JP, Udy AA, Sousa E, et al. A comparison of estimates of glomerular filtration in critically ill patients with augmented renal clearance. Crit Care. 2011;15(3):R139 . doi:10.1186/cc10262
   PubMed Web of Science ®Google Scholar
• Toprak O, Cirit M. Risk factors and therapy strategies for contrast-induced nephropathy. Ren Fail. 2006;28(5):365–381
   PubMed Web of Science ®Google Scholar
• Taylor AJ, Hotchkiss D, Morse RW, et al. PREPARED: preparation for angiography in renal dysfunction: a randomized trial of in patient vs out patient hydration protocols for cardiac catheterization in mild-to-moderate renal dysfunction. Chest. 1998;114:1570–1574
   PubMed Web of Science ®Google Scholar
• Mueller C, Buerkle G, Buettner HJ, et al. Prevention of contrast-media associated nephropathy: randomized comparison of 2 hydration regimens in 1620 patient undergoing coronary angioplasty. Arch Intern Med. 2002;162:329–336
   PubMed Web of Science ®Google Scholar
• Oguzhan N, Cilan H, Sipahioglu M, et al. The lack of benefit of a combination of an angiotensin receptor blocker and calcium channel blocker on contrast-induced nephropathy in patients with chronic kidney disease. Ren Fail. 2013;35(4):434–439
   PubMed Web of Science ®Google Scholar
• Merten GJ, Burgess WP, Gray LV, et al. Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial. J Am Med Assoc. 2004;291(19):2328–2334
   PubMed Web of Science ®Google Scholar
• Hogan SE, LAllier P, Chetcuti S, et al. Current role of sodium bicarbonate-based preprocedural hydration for the prevention of contrast-induced acute kidney injury: a meta-analysis. Am Heart J. 2008;156:414–421
   PubMedGoogle Scholar
• Meier P, Ko DT, Tamura A, Tamhane U, Gurm HS. Sodium bicarbonate-based hydration prevents contrastinduced nephropathy: a meta-analysis. BMC Med. 2009;13:7–23
   Google Scholar
• Jang JS, Jin HY, Seo JS, et al. Sodium bicarbonate therapy for the prevention of contrast-induced acute kidney injury – a systematic review and meta-analysis. Circ J. 2012;76(9):2255–2265
   PubMedGoogle Scholar
• Wang YX, Jia YF, Chen KM, Morcos SK. Radiographic contrast media induced nephropathy: experimental observations and the protective effect of calcium channel blockers. Br J Radiol. 2001;74(888):1103–1108
   PubMedGoogle Scholar
• Esnault VL. Radiocontrast media-induced nephrotoxicity in patients with renal failure: rationale for a new double-blind, prospective, randomized trial testing calcium channel antagonists. Nephrol Dial Transplant. 2002;17(8):1362–1364
   PubMedGoogle Scholar
• Duan SB, Liu FY, Luo JA, et al. Nephrotoxicity of high- and low-osmolar contrast media. The protective role of amlodipine in a rat model. Acta Radiol. 2000;41:503–507
   PubMed Web of Science ®Google Scholar
• Khoury Z, Schlicht JR, Como J, et al. The effect of prophylactic nifedipine on renal function in patients administered contrast media. Pharmacotherapy. 1995;15(1):59–65
   PubMedGoogle Scholar
• Russo D, Testa A, Della Volpe L, et al. Randomised prospective study on renal effects of two different contrast media in humans: protective role of a calcium channel blocker. Nephron. 1990;55(3):254–257
   PubMedGoogle Scholar
• Spangberg-Viklund B, Berglund J, Nikonoff T, et al. Does prophylactic treatment with felodipine, a calcium antagonist, prevent low-osmolar contrast-induced renal dysfunction in hydrated diabetic and nondiabetic patients with normal or moderately reduced renalfunction?. Scand J Urol Nephrol. 1996;30(1):63–68
   PubMed Web of Science ®Google Scholar
• Costanzi S, Danza F, Neri A, Passalacqua S, Fulignati P, Splendiani G. Use of felodipine to prevent radyokontrast nefropathy(RCN). J Am Soc Nephrol. 1994;5:s390–s394
   Google Scholar